| 标题 |
High Safety and Efficacy of CRISPR-Based Non-Viral PD-1 Locus Specific Integrated Anti-CD19 CAR-T Cells (BRL-201) in Treating Relapsed or Refractory Non-Hodgkin's Lymphoma: First-in-Human Phase I Study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Blood 作者:Yongxian Hu; Jiqin Zhang; Mingming Zhang; Wei Li; Wenjun Wu; et al 出版日期:2022-11-29 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)